News
-
According to Insmed, the company has filed an MAA for its Arikayce liposomal amikacin for inhalation, and it has been informed by the EMA that the only remaining issue, a review of the Pediatric Investigation… Read more . . .
-
Hovione has announced that the FDA has found its Loures, Portugal manufacturing site to be GMP compliant, although the agency issued a Form 483 citing three inspectional observations. The inspection took place from December 1… Read more . . .
-
Submit poster abstracts by May 31, 2015. More information available at http://www.tefarco.it/TB2015/pages/posters.aspx# Read more . . .
-
Lightlake Therapeutics has agreed to license its intranasal naloxone for opioid overdose reversal to Adapt Pharma for possible development and sales milestones of more than $55 million, plus royalties, the company said. Lightlake recently announced… Read more . . .
-
GSK has announced that it will change the color of the Relvar Ellipta fluticasone/vilanterol DPI starting in January 2015. The company said that it will remove the color blue from the inhaler and its packaging… Read more . . .
-
Acorda Therapeutics has announced the enrollment of the first patient in a Phase 3 study of CVT-301 inhaled L-dopa for the treatment of OFF episodes in Parkinson’s disease (PD). The study is expected to enroll… Read more . . .
-
Cystic Fibrosis Foundation Therapeutics (CFFT), a nonprofit associated with the Cystic Fibrosis Foundation, has announced that it will provide Shire with up to $15 million for development of an aerosol messenger RNA therapy designed to… Read more . . .
-
Submit podium abstracts by March 9, 2015 and poster abstracts by May 9 2015 at http://www.inhalationasia.org/conference/inhalation-asia-15/present. Inhalation Asia offers open access to its conference archive; authors must consent to making presentations and/or posters available at… Read more . . .
-
Pfizer has launched Novartis’ Ultibro Breezhaler indacaterol/glycopyrronium DPI for the treatment of COPD in the UK, the company said. Ultibro Breezhaler was approved in Europe in September 2013. In September 2014, Pfizer announced that it… Read more . . .
-
Submit 3-5 page double-space poster abstracts by January 9, 2015 online at http://www.rddonline.com/rdd/poster_reg.php?id=11. Poster guidelines can be found at http://www.rddonline.com/rdd/rdd.php?id=11&sid=4&sub=358 Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.